These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1350610)

  • 21. Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids.
    Barbosa DS; Cecchini R; El Kadri MZ; Rodríguez MA; Burini RC; Dichi I
    Nutrition; 2003 Oct; 19(10):837-42. PubMed ID: 14559317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The management of ulcerative colitis.
    Watkinson G
    Practitioner; 1976 Jun; 216(1296):642-8. PubMed ID: 7781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind placebo-controlled study of olsalazine in the treatment of ulcerative colitis.
    Zinberg J; Molinas S; Das KM
    Am J Gastroenterol; 1990 May; 85(5):562-6. PubMed ID: 2337059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative efficacy of mezakol and sulfasalazine in treating chronic relapsing ulcerative colitis].
    Rogozina VA; Rumiantsev VG
    Eksp Klin Gastroenterol; 2003; (1):58-9, 183. PubMed ID: 12664788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA
    Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paradoxical response to heparin in 10 patients with ulcerative colitis.
    Gaffney PR; Doyle CT; Gaffney A; Hogan J; Hayes DP; Annis P
    Am J Gastroenterol; 1995 Feb; 90(2):220-3. PubMed ID: 7847289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H; Munakata A; Yoshida Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis.
    Lichtenstein GR; Kamm MA; Boddu P; Gubergrits N; Lyne A; Butler T; Lees K; Joseph RE; Sandborn WJ
    Clin Gastroenterol Hepatol; 2007 Jan; 5(1):95-102. PubMed ID: 17234558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group.
    Hanauer S; Schwartz J; Robinson M; Roufail W; Arora S; Cello J; Safdi M
    Am J Gastroenterol; 1993 Aug; 88(8):1188-97. PubMed ID: 8338086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensive granulocyte and monocyte adsorption versus intravenous prednisolone in patients with severe ulcerative colitis: an unblinded randomised multi-centre controlled study.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Maruyama Y; Kageoka M; Ikeya K; Yamada M; Kikuyama M; Iwaoka Y; Hirayama K; Nagata S; Sato Y; Hosoda Y
    Dig Liver Dis; 2008 Jun; 40(6):433-40. PubMed ID: 18296130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
    Hanauer SB; Sandborn WJ; Kornbluth A; Katz S; Safdi M; Woogen S; Regalli G; Yeh C; Smith-Hall N; Ajayi F
    Am J Gastroenterol; 2005 Nov; 100(11):2478-85. PubMed ID: 16279903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scavengers of oxygen-derived free radicals prolong survival in advanced colonic cancer. A new approach.
    Salim AS
    Tumour Biol; 1993; 14(1):9-17. PubMed ID: 8493453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Salazosulfapyridine-induced lupus erythematosus syndrome in ulcerative colitis (author's transl)].
    Jaup BH
    Dtsch Med Wochenschr; 1978 Jul; 103(30):1211-3. PubMed ID: 27347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A possible new approach to the problem of refractory peptic ulceration. A role for free radical scavengers?
    Salim AS
    Scott Med J; 1991 Feb; 36(1):19-20. PubMed ID: 1851575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxygen-derived free radicals and the prevention of duodenal ulcer relapse: a new approach.
    Salim AS
    Am J Med Sci; 1990 Jul; 300(1):1-6; discussion 7-8. PubMed ID: 2164771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ulcerative colitis and its management, with special reference to the acute attack and its management].
    Ishikawa M; Tsuboi M
    Nihon Rinsho; 1977 May; 35(5):1877-81. PubMed ID: 18626
    [No Abstract]   [Full Text] [Related]  

  • 37. Stimulation of healing by free radical scavengers of ischemia-induced acute gastric mucosal injury in the rat.
    Salim AS
    J Pharm Sci; 1992 Nov; 81(11):1095-7. PubMed ID: 1447712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).
    Dissanayake AS; Truelove SC
    Gut; 1973 Dec; 14(12):923-6. PubMed ID: 4150435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Removing oxygen-derived free radicals stimulates healing of ethanol-induced erosive gastritis in the rat.
    Salim AS
    Digestion; 1990; 47(1):24-8. PubMed ID: 2292345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of severe attacks of ulcerative colitis.
    Binder SC; Katz B
    Ohio State Med J; 1978 Mar; 74(3):167-9. PubMed ID: 24823
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.